You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 17, 2024

DIETHYLPROPION HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Diethylpropion Hydrochloride patents expire, and what generic alternatives are available?

Diethylpropion Hydrochloride is a drug marketed by Lannett Co Inc, Avanthi Inc, Chartwell Rx, Epic Pharma Llc, Sandoz, Teva, Ucb Inc, and Watson Labs. and is included in ten NDAs.

The generic ingredient in DIETHYLPROPION HYDROCHLORIDE is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Diethylpropion Hydrochloride

A generic version of DIETHYLPROPION HYDROCHLORIDE was approved as diethylpropion hydrochloride by AVANTHI INC on December 22nd, 2010.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DIETHYLPROPION HYDROCHLORIDE?
  • What are the global sales for DIETHYLPROPION HYDROCHLORIDE?
  • What is Average Wholesale Price for DIETHYLPROPION HYDROCHLORIDE?
Summary for DIETHYLPROPION HYDROCHLORIDE
US Patents:0
Applicants:8
NDAs:10
Finished Product Suppliers / Packagers: 11
Raw Ingredient (Bulk) Api Vendors: 39
Clinical Trials: 2
Patent Applications: 643
What excipients (inactive ingredients) are in DIETHYLPROPION HYDROCHLORIDE?DIETHYLPROPION HYDROCHLORIDE excipients list
DailyMed Link:DIETHYLPROPION HYDROCHLORIDE at DailyMed
Drug patent expirations by year for DIETHYLPROPION HYDROCHLORIDE
Recent Clinical Trials for DIETHYLPROPION HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GlaxoSmithKline
New River PharmaceuticalsPhase 1/Phase 2

See all DIETHYLPROPION HYDROCHLORIDE clinical trials

Pharmacology for DIETHYLPROPION HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DIETHYLPROPION HYDROCHLORIDE

US Patents and Regulatory Information for DIETHYLPROPION HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Co Inc DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 091680-001 Oct 24, 2011 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET;ORAL 085916-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET;ORAL 088268-001 Aug 25, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.